Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M145Revenue (TTM) $M0.2Net Margin (%)-51,398.1Altman Z-Score-3.0
Enterprise Value $M62.2EPS (TTM) $-1.3Operating Margin %-51,410.1Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-51,396.9Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %-19.3Quick Ratio3.5Cash flow > EarningsY
Price/Sales4905-y EBITDA Growth Rate %-0.6Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-94.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M74.2ROIC % (ttm)-570.0Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 1.96-85%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 1.96-89%New holding44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GIVEN DOUGLAS BDirector 2016-10-14Sell12,000$6.72-70.83view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-75.5view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-75.5view
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.13-68.03view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-75.53view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-68.99view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-68.99view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-86.67view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-86.95view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-87.14view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
IMPORTANT ARWR SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit... Jan 14 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead... Jan 13 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of... Jan 13 2017
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 12 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Jan 12 2017
These 3 Biotech Stocks Are Already Moving Wildly on Thursday Jan 12 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 10 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a... Jan 09 2017
Monday’s 4 Biggest Biopharma Movers Jan 09 2017
Arrowhead Provides Response to New Minority Shareholder Announcement Jan 09 2017
DEADLINE ALERT: Brower Piven Reminds Investors Of The January 16, 2017 Deadline In Class Action... Jan 07 2017
ARWR LOSS NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important... Jan 06 2017
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 05 2017
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Jan 04 2017
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Jan 03 2017
ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : January 3, 2017 Jan 03 2017
ARWR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action... Jan 03 2017
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Dec 28 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 28 2016
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Arrowhead... Dec 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)